Skip to main content
SpringerLink
Log in

Drug-Induced Pancreatitis

  • Review Article
  • Pharmacoepidemiology
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

Few data exist about the incidence of drug-induced pancreatitis in the general population. 20 cases of drug-related pancreatitis were reported in Switzerland over a period of 12 years. The proportion of cases of pancreatitis caused by drugs is estimated to be around 2% in the general population, with much higher proportions in specific subpopulations, such as children and patients who are HIV positive. The literature about drug-induced pancreatitis consists mainly of anecdotal case reports. Clear evidence of a definite association with pancreatitis, by means of rechallenge tests, or consistent case reports, supported by animal experiments or data on the incidence of acute pancreatitis in drug trials exists for didanosine, valproic acid (sodium valproate), aminosalicylates, estrogen, calcium, anticholinesterases and sodium stibogluconate. An association with drug-induced pancreatitis is likely but not definitely proven for thiazide diuretics, pentamidine, ACE inhibitors, asparaginase, vinca alkaloids, some nonsteroidal anti-inflammatory drugs and clozapine. Pancreatitis is possibly caused by azathioprine, furosemide (frusemide), tetracycline, metronidazole, isoniazid, rifampicin (rifampin), sulphonamides, cyclosporin and some antineoplastic drugs. Many drugs have been reported to be associated with acute pancreatitis. However, lack of rechallenge evidence, consistent statistical data, or evidence from experimental studies on a possible mechanism prohibit definitive conclusions about most of them. The high incidence of concurrent illnesses known to induce acute pancreatitis, makes a trigger role or co-factor role for the drug seem most likely.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Werth B, Kuhn MK H, Reinhart WH. Medikamentös induzierte Pankreatiden: Erfahrungen der Schweizerischen Arzneimittel-Nebenwirkungenszentrale (SANZ) 1981–1993. Schweiz Med Wochenschr 1995; 125: 731–4

    PubMed  CAS  Google Scholar 

  2. Steinberg W. Acute pancreatitis. N Engl J Med 1994; 330(17): 1198–210

    Article  PubMed  CAS  Google Scholar 

  3. Corfield AP, Cooper MJ, Williamson RCN. Acute pancreatitis: a lethal disease of increasing incidence. Gut 1985; 26: 724–9

    Article  PubMed  CAS  Google Scholar 

  4. Thomson S, Hendry W, McFarlane G, et al. Epidemiology and outcome of acute pancreatitis. Br J Surg 1987; 74: 398–401

    Article  PubMed  CAS  Google Scholar 

  5. Lankisch PG, Dräge M, Gottesleben F. Drug induced pancreatitis: incidence and severity. Gut 1995; 37: 565–7

    Article  PubMed  CAS  Google Scholar 

  6. Cappell MS, Marks M. Acute pancreatitis in HIV-seropositive patients: a case control study in 44 patients. Am J Med 1995; 98: 243–8

    Article  PubMed  CAS  Google Scholar 

  7. Karch FE, Lasagna L. Adverse drug reactions: a critical review. JAMA 1975; 234(12): 1236–41

    Article  PubMed  CAS  Google Scholar 

  8. Bireher J. Criteria for the diagnosis of adverse drug reactions. Baillieres Clin Gastroenterol 1988; 2: 259–61

    Article  Google Scholar 

  9. Bouvert E, Casalino E, Prevost M, et al. Fatal case of 2′,3′-dideoxyinosine-associated pancreatitis. Lancet 1990; 336: 1515

    Article  Google Scholar 

  10. Schindzielorz A, Pike I, Daniels M, et al. Rates and risk factors for adverse events associated with didanosine in the expanded access program. Clin Infect Dis 1994; 19(6): 1076–83

    Article  PubMed  CAS  Google Scholar 

  11. Maxson C, Greenfield S, Turner J. Acute pancreatitis as a common complication of 2′3′-dideoxyinosine therapy in the acquired immunodeficiency syndrome. Am J Gastroenterol 1992; 87(6): 708–13

    PubMed  CAS  Google Scholar 

  12. Yarchoan R, Mitsuya H, Pluda J, et al. The national cancer institute phase I study of 2′,3′-dideoxyinosine administration in adults with AIDS-related complex: analysis of activity and toxicity profiles. Rev Infect Dis 1990; 12: S522–S233

    Article  PubMed  Google Scholar 

  13. Valentine F, Seidlin M, Hockster H, et al. Phase I study of 2′,3′-dideoxyinosine: experience with 19 patients at New York University Medical Center. Rev Infect Dis 1990; 12: S534–S539

    Article  PubMed  Google Scholar 

  14. Rozencweig M, McLaren C, Beltangady M, et al. Overview of Phase I trials of 2′,3′-dideoxyinosine (ddl) conducted on adult patients. Rev Infect Dis 1990; 12: S570–S575

    Article  PubMed  Google Scholar 

  15. Dolin R, Lambert J, Morse G, et al. 2′3′-Dideoxyinosine in patients with AIDS or AIDS-related complex. Rev Infect Dis 1990; 12: S540–S551

    Article  PubMed  Google Scholar 

  16. Butler K, Husson R, Balis F, et al. Dideoxyinosine in children with symptomatic human immunodeficiency virus infection. N Engl J Med 1991; 324: 137–144

    Article  PubMed  CAS  Google Scholar 

  17. Cooley T, Knuches L, Saunders C, et al. Treatment of AIDS and AIDS-related complex with 2′,3′-dideoxyinosine given once daily. Rev Infect Dis 1990; 12: S552–S560

    Article  PubMed  Google Scholar 

  18. Seidlin M, Lambert JS, Dolin R, et al. Pancreatitis and pancreatic dysfunction in patients taking dideoxyinosine. AIDS 1992; 6: 831–5

    Article  PubMed  CAS  Google Scholar 

  19. Grasela T, Walawander C, Beltangady M, et al. Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine. J Infect Dis 1994; 169: 1250–5

    Article  PubMed  CAS  Google Scholar 

  20. Butler K, Venzon D, Henry N, et al. Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine. Pediatrics 1993; 91: 747–51

    PubMed  CAS  Google Scholar 

  21. Lambert J, Seidlin M, Valentine F, et al. Didanosine: long term follow up of patients in a phase I study CID 1993; 16(Suppl. 1): S40–S45

    Article  Google Scholar 

  22. Moyle G, Nelson M, Hawkins D, et al. The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine (AZT). Q J Med 1993; 86: 155–63

    PubMed  CAS  Google Scholar 

  23. Brivet F, Coffin B, Bedossa P, et al. Pancreatic lesions in AIDS. Lancet 1987; II: 570–1

    Article  Google Scholar 

  24. Clas D, Falutz J, Rosenberg L. Acute pancreatitis associated with HIV infection. Can Med Assoc J 1989; 140: 823

    CAS  Google Scholar 

  25. Schwartz M, Brandt L. The spectrum of pancreatic disorders in patients with the Acquired Immune Deficiency Syndrome. Am J Gastroenterol 1989; 84(5): 459–62

    PubMed  CAS  Google Scholar 

  26. Asconape J, Penry J, Dreifuss F, et al. Valproate-associated pancreatitis. Epilepsia 1993; 34: 177–83

    Article  PubMed  CAS  Google Scholar 

  27. Binek J, Hany A, Heer M. Valproic-acid-induced pancreatitis Case report and review of the literature. J Clin Gastroenterol 1991; 13(6): 690–3

    Article  PubMed  CAS  Google Scholar 

  28. Kayemba Kay’s Kabangu S, Bovier Lapierre M, Jalaquier E. Pancreatite aigue et acide valproique. Pediatrie 1991; 46(12): 839–43

    PubMed  Google Scholar 

  29. Williams L, Emery J. Pancreatitis during sodium valproate treatment. Arch Dis Child 1983; 58: 543–4

    Article  PubMed  CAS  Google Scholar 

  30. Rosenberg H, Ortega W. Hemorrhagic pancreatitis in a young child following valproic acid therapy. Clin Pediatr 1987; 26: 98–101

    Article  CAS  Google Scholar 

  31. Wyllie E, Wyllie R, Cruse R, et al. Pancreatitis associated with valproic acid therapy. Am J Dis Child 1984; 138: 912–4

    PubMed  CAS  Google Scholar 

  32. Ng J, Disney A, Jones T, et al. Acute pancreatitis and sodium valproate. Med J Aust 1982; 21: 362

    Google Scholar 

  33. Murphy M, Lyon L, Taylor J. Valproic acid associated pancreatitis in an adult. Lancet 1981; I: 41–2

    Article  Google Scholar 

  34. Lott J, Bond L, Bobo R, et al. Valproic acid-associated pancreatitis: Report of three cases and a brief review. Clin Chem 1990; 36: 395–7

    PubMed  CAS  Google Scholar 

  35. Coulter D, Allen R. Pancreatitis associated with valproic acid therapy for epilepsy. Ann Neurol 1980; 7: 92

    Article  PubMed  CAS  Google Scholar 

  36. Camfield P, Bagnell P, Camfield C, et al. Pancreatitis due to valproic acid [letter]. Lancet 1979; I: 1198

    Article  Google Scholar 

  37. Batalden P, Van Dyne B, Cloyd J. Pancreatitis associated with valproic acid therapy. Pediatrics 1979; 64: 520–2

    PubMed  CAS  Google Scholar 

  38. Parker P, Helinek G, Ghishan F, et al. Recurrent pancreatitis induced by valproic acid. Gastroenterology 1981; 80: 826–8

    PubMed  CAS  Google Scholar 

  39. Sasaki M, Tonoda S, Aoki Y, et al. Pancreatitis due to valproic acid [letter]. Lancet 1980; I: 1196

    Article  Google Scholar 

  40. Committee on Safety of Medicines. Drug-induced pancreatitis. In: Rawlings M. Langman M, Wood S, et al, editors. Current Problems in Pharmacovigilance. London: Medicines Control Agency, 1994: 2–3

    Google Scholar 

  41. Walker R, Smith G, Barsoum N, et al. Preclinical toxicology of the anticonvulsant calcium valproate. Toxicology 1990; 63: 137–55

    Article  PubMed  CAS  Google Scholar 

  42. Block M, Genant H, Kirsner J. Pancreatitis as an adverse reaction to salicylazosulfapyridine. N Engl J Med 1970; 282: 380–2

    Article  PubMed  CAS  Google Scholar 

  43. Faintuch J, Mott C, Machado M. Pancreatitis and pancreatic necrosis during sulfasalazine therapy. Int Surg 1985; 70: 271–2

    PubMed  CAS  Google Scholar 

  44. Suryapranta H, deVries H. Pancreatitis associated with sulfasalazine. BMJ 1986; 292: 732

    Article  Google Scholar 

  45. Rubin R. Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis. Am J Gastroenterol 1994; 89: 789–91

    PubMed  CAS  Google Scholar 

  46. Abdullah A, Scott R, Martin S. Acute pancreatitis secondary to 5-aminosalicylic acid in a child with Ulcerative Colitis. J Pediatr Gastroenterol Nutr 1993; 17: 441–4

    Article  PubMed  CAS  Google Scholar 

  47. Debongnie J, Dekoninck X. Sulfasalazine, 5-ASA and acute pancreatitis in Crohn’s Disease. J Clin Gastroenterol 1994; 19: 348–9

    Article  PubMed  CAS  Google Scholar 

  48. Delgado Fontaneda E, Garcia Campos F, Ruiz Rebollo L, et al. Pancreatitis aguda por salazopirina — una asociacion excepcional. Rev Esp Enferm Dig 1991; 79: 439–40

    PubMed  CAS  Google Scholar 

  49. Erdkamp F, Houben M, Ackerman E, et al. Pancreatitis induced by mesalazine. Neth J Med 1992; 41: 71–2

    PubMed  CAS  Google Scholar 

  50. Garau P, Orenstein S, Neigut D, et al. Pancreatitis associated with olsalazine and sulfasalazine in children with ulcerative colitis. J Pediatr Gastroenterol Nutr 1994; 18: 481–5

    Article  PubMed  CAS  Google Scholar 

  51. Radke M, Bartolomaeus G, Müller M, et al. Acute pancreatitis in Crohn’s disease due to 5-ASA therapy. J Pediatr Gastroenterol Nutr 1993; 16: 337–9

    Article  PubMed  CAS  Google Scholar 

  52. Chiba M, Horie Y, Ishida H, et al. A case of salicylazosulfapyridine induced acute pancreatitis with positive lymphocyte stimulation test. Gastroenterol Jpn 1987; 22: 228–33

    PubMed  CAS  Google Scholar 

  53. Brazer S, Medoff J. Sulfonamide-induced pancreatitis Pancreas 1988; 5: 583–6

    Article  Google Scholar 

  54. Van Arsdel PJ. Adverse drug reactions. St Louis: The C.V. Mosby Co, 1983: 1389–414

    Google Scholar 

  55. Poldermans D, Van Blankenstein M. Pancreatitis induced by disodium azodisalicylate. Am J Gastroenterol 1988; 83: 578–80

    PubMed  CAS  Google Scholar 

  56. Howard J. Pancreatitis: multiple diseases with multiple causes and varying natural histories. In: Howard J, Jordan G, Reber H, editors. Surgical diseases of the pancreas. Philadelphia: Lea&Febiger, 1987: 204–7

    Google Scholar 

  57. Eisner T, Goldman I, Mc Kinley M. Crohn’s disease and pancreatitis. Am J Gastroenterol 1993; 88: 583–6

    PubMed  CAS  Google Scholar 

  58. Weber P, Seibold F, Jenss H. Acute pancreatitis in Crohn’s disease. J Clin Gastroenterol 1993; 17(4): 286–91

    Article  PubMed  CAS  Google Scholar 

  59. Bank S, Marks I. Hyperlipemic pancreatitis and the pill. Postgrad Med J 1970; 46: 576–88

    Article  PubMed  CAS  Google Scholar 

  60. Glueck C, Scheel D, Fishback J, et al. Estrogen induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia. Metabolism 1972; 21: 657–66

    Article  PubMed  CAS  Google Scholar 

  61. Mungall I, Hague R. Pancreatitis and the pill. Postgrad Med J 1975; 51: 855–7

    Article  PubMed  CAS  Google Scholar 

  62. Davidoff F, Tishler S, Rosoff C. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. N Engl J Med 1973; 289: 552–5

    Article  PubMed  CAS  Google Scholar 

  63. Foster M, Powell D. Pancreatitis, multiple infarcts and oral contraception. Postgrad Med J 1975; 51: 667–9

    Article  PubMed  CAS  Google Scholar 

  64. Parker W. Estrogen-induced pancreatitis (clinical conference). Clin Pharm 1983; 2: 75–9

    PubMed  CAS  Google Scholar 

  65. Schaefer J, Steinmetz A, Dugi K, et al. Durch orale Kontrazeptiva induzierte Pankreatitis bei Hyperchylomikronamie-Syndrom. Deutsch Med Wochenschr 1995; 120: 325–8

    Article  CAS  Google Scholar 

  66. Glueck C, Lang J, Hamer T, et al. Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women. J Lab Clin Med 1994; 123: 59–64

    PubMed  CAS  Google Scholar 

  67. Zorilla E, Hulse M, Hernandez A, et al. Severe endogenous hypertriglyceridemia during treatment with estrogen and oral contraceptives. J Clin Endocrinol 1968; 28: 1793–6

    Article  Google Scholar 

  68. Frick T, Fryd D, Sutherland D, et al. Hypercalcemia associated with pancreatitis and hyperamylasemia in renal transplant recipients: data from the Minnesota randomized trial of cyclosporine versus antilymphoblast azathioprine. Am J Surg 1987; 154: 487–9

    Article  PubMed  CAS  Google Scholar 

  69. Mixter CJ, Keynes M, Cope O. Further experience with pancreatitis as a diagnostic clue to hyperparathyroidism. N Engl J Med 1962; 266: 265–72

    Article  Google Scholar 

  70. Payne J, Tanenberg R. Hyperparathyroid crisis and acute necrotizing pancreatitis presenting as diabetic ketoacidosis. Am J Surg 1980; 140: 698–703

    Article  PubMed  Google Scholar 

  71. Gafter U, Mandel EM, Har Zahav L, et al. Acute pancreatitis secondary to hypercalcemia: occurrence in a patient with breast carcinoma. JAMA 1976; 235: 2004–5

    Article  PubMed  CAS  Google Scholar 

  72. May P, Levy R. Thyrotoxicosis associated with renal tubular necrosis and acute pancreatitis: a case report. Ann Intern Med 1976; 84: 569–70

    PubMed  CAS  Google Scholar 

  73. Davies M, Kliniuk P, Adams P, et al. Familial hypocalciuric hypercalcemia and acute pancreatitis. BMJ 1981; 282: 1023–5

    Article  PubMed  CAS  Google Scholar 

  74. Meltzer L, Palmon F, Paik Y, et al. Acute pancreatitis secondary to hypercalcemia of multiple myeloma. Ann Intern Med 1962; 57: 1008–12

    PubMed  CAS  Google Scholar 

  75. Fernández-del Castillo C, Harringer W, Warshaw A, et al. Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med 1991; 325: 382–7

    Article  PubMed  Google Scholar 

  76. Hochgelerent E, David D. Acute pancreatitis secondary to calcium infusion in a dialysis patient. Arch Surg 1974; 108: 218–9

    Article  PubMed  CAS  Google Scholar 

  77. Izsak E, Shilke M, Roulet M, et al. Pancreatitis in association with hypercalcemia in patients receiving total parenteral nutrition. Gastroenterology 1980; 79: 555–8

    PubMed  CAS  Google Scholar 

  78. Manson R. Acute pancreatitis secondary to iatrogenic hypercalcemia: implications of hyperalimentation. Arch Surg 1974; 108: 213–5

    Article  PubMed  CAS  Google Scholar 

  79. Evans D, Slapak M. Pancreatitis in the hard water syndrome. BMJ 1975; 3: 748

    Article  PubMed  CAS  Google Scholar 

  80. DeWaele B, Smith J, Willems G. Recurrent pancreatitis secondary to hypercalcemia following vitamin D poisoning. Pancreas 1989; 4: 378–80

    Article  Google Scholar 

  81. Leeson P, Fourman P. Acute pancreatitis from vitamin-D poisoning in a patient with parathyroid deficiency Lancet 1966; I: 1185–6

    Article  Google Scholar 

  82. Cates M, Singh S, Peick A, et al. Acute hypercalcemia, pancreatic duct permeability, and pancreatitis in cats. Surgery 1988; 104: 137–41

    PubMed  CAS  Google Scholar 

  83. Frick T, Hailemariam S, Heitz P, et al. Acute hypercalcemia induces acinar cell necrosis and intraductal precipitates in the pancreas of cat and guinea pig. Gastroenterology 1990; 98: 1675–81

    PubMed  CAS  Google Scholar 

  84. Kelly T. Relationship of hyperparathyroidism and pancreatitis. Arch Surg 1968; 97: 267–74

    Article  PubMed  CAS  Google Scholar 

  85. Schmidt H, Creutzfeld T. Calciphylactic pancreatitis and pancreatitis in hyperparathyroidism. Clin Orthop 1970; 69: 135–45

    PubMed  CAS  Google Scholar 

  86. Renner I, Savage W, Pantoja J, et al. Death due to acute pancreatitis: a retrospective analysis of 405 autopsy cases. Dig Dis Sci 1985; 30: 1005–18

    Article  PubMed  CAS  Google Scholar 

  87. Bleyl U. Die sogenannte nervale Pankreatitis und ihre pathophysiologischen Grundlagen. Z Gastroenterol 1963; 1: 335–50

    Google Scholar 

  88. Dressel T, Goodale Jr R, Arneson M, et al. Pancreatitis as a complication of anticholinesterase insecticide intoxication. Ann Surg 1979; 189: 199–204

    Article  PubMed  CAS  Google Scholar 

  89. Dagli A, Shaikh W. Pancreatic involvement in malathion-anti-cholinesterase insecticide intoxication: a study of 75 cases. Br J Clin Pract 1983; 37: 270–2

    PubMed  CAS  Google Scholar 

  90. Lankisch P, Müller C, Niederstadt H, et al. Painless acute pancreatitis subsequent to anticholinesterase insecticide (parathion) intoxication. Am J Gastroenterol 1990; 85: 872–5

    PubMed  CAS  Google Scholar 

  91. Marsh W, Vukov G, Conradi E. Acute pancreatitis after cutaneous exposure to an organophosphate insecticide. Am J Gastroenterol 1988; 83: 1158–60

    PubMed  CAS  Google Scholar 

  92. Moore P, James O. Acute pancreatitis induced by acute organophosphate poisoning? Postgrad Med J 1981; 57: 660–2

    Article  PubMed  CAS  Google Scholar 

  93. Moritz F, Droy J, Dutheil G, et al. Acute pancreatitis after carbamate insecticide intoxication. Intensive Care Med 1994; 20: 49–50

    Article  PubMed  CAS  Google Scholar 

  94. Weizman Z, Sofer S. Acute pancreatitis in children with anticholinesterase insecticide intoxication. Pediatrics 1992; 90: 204–6

    PubMed  CAS  Google Scholar 

  95. Dressel T, Goodale Jr R, Zweber B, et al. The effect of atropine and duct decompression on the evolution of diazinon-induced acute canine pancreatitis. Ann Surg 1982; 195: 424–34

    Article  PubMed  CAS  Google Scholar 

  96. Frick T, Dalo S, O’Leary J, et al. Effects of insecticide, diazinon, on pancreas of dog, cat and guinea pig. J Environ Pathol Toxicol Oncol 1987; 7: 1–11

    PubMed  CAS  Google Scholar 

  97. Laguna F, Soriano V, González-Labor J. Misdiagnosis in patients receiving treatment with pentavalent antimonal patients. Clin Infect Dis 1994; 19: 978–9

    PubMed  CAS  Google Scholar 

  98. McCarthy A, Keystone J, Kain K. Pancreatitis occurring during therapy with stibogluconate: two case reports. Clin Infect Dis 1993; 17: 952–3

    Article  PubMed  CAS  Google Scholar 

  99. Halim M, Alfurayh O, Kalin M, et al. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate. Clin Infect Dis 1993; 16: 397–9

    Article  PubMed  CAS  Google Scholar 

  100. de Lalla F, Pellizer G, Gradoni L, et al. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral Leishmaniasis. Clin Infect Dis 1993; 16: 730–1

    Article  PubMed  Google Scholar 

  101. Donovan K, White A, Cooke D, et al. Pancreatitis and palindromic arthropathy with effusions associated with sodium stibogluconate treatment in a renal transplant patient. J Infect 1990; 21: 107–10

    Article  PubMed  CAS  Google Scholar 

  102. Eckhauser M, Dokler M, Imbembo A. Diuretic-associated pancreatitis: a collective review and illustrative cases. Am J Gastroenterol 1987; 82: 865–70

    PubMed  CAS  Google Scholar 

  103. Prigogine T, Futeral B, Kraytman M. Acute hemorrhagic pancreatitis associated with chlorthalidone therapy. Acta Clin Belg 1978; 33: 272

    Google Scholar 

  104. McCormick P, Malone D, Fitzgerald M, et al. Pancreatitis in sarcoidosis. BMJ 1985; 290: 1472–3

    Article  PubMed  CAS  Google Scholar 

  105. Pickleman J, Straus F, Paloyan E. Pancreatitis associated with thiazide administration. Arch Surg 1979; 114: 1013–6

    Article  PubMed  CAS  Google Scholar 

  106. Wenger J, Gross P. Acute hemorrhagic pancreatitis related to hydrochlorothiazide therapy. Gastroenterology 1964; 46: 768

    Google Scholar 

  107. Johnston D, Cornish A. Acute pancreatitis in patients receiving chlorothiazide. JAMA 1959; 170: 2054–6

    Article  CAS  Google Scholar 

  108. Diamond M. Hyperglycemic hyperosmolar coma associated with hydrochlorothiazide and pancreatitis. NY State J Med 1972; 72: 1741–2

    CAS  Google Scholar 

  109. Ances I, McClain C. Acute pancreatitis following the use of thiazide in pregnancy. South Med J 1971; 64: 267–9

    Article  PubMed  CAS  Google Scholar 

  110. Jones M, Caldwell J. Acute hemorrhagic pancreatitis associated with administration of chlorthialidone. N Engl J Med 1962; 267: 1029–30

    Article  PubMed  CAS  Google Scholar 

  111. Minkowitz S, Soloway H, Hall J, et al. Fatal hemorrhagic pancreatitis following chlorothiazide administration in pregnancy. Obstet Gynecol 1964; 24: 337–42

    PubMed  CAS  Google Scholar 

  112. Rion J. Recurrent pancreatitis after treatment with hydrochlorthiazide. J Am Board Fam Pract 1994; 7: 74–6

    PubMed  CAS  Google Scholar 

  113. Fuchs J, Keith M, Galanos A. Probable metolazone-induced pancreatitis. DICP 1989; 23: 711

    PubMed  Google Scholar 

  114. Andersson P, Ellis G, Austin S. Metolazone-associated hypercalcemia and acute pancreatitis. Am J Med Sci 1991; 302: 235–7

    Article  Google Scholar 

  115. Mussche M, DeBroe M, Belpaire F, et al. Oral diazoxide contraindicated in severe hypertension with renal failure. Clin Nephrol 1975; 4: 99–103

    PubMed  CAS  Google Scholar 

  116. Cornish A, McClellan J, Johnston D. Effects of chlorothiazide on the pancreas. N Engl J Med 1961; 265: 673–5

    Article  PubMed  CAS  Google Scholar 

  117. Edwards B, Baer P, Sutton R, et al. Micropuncture study of diuretic effects on sodium and calcium reabsorption in the dog nephron. J Clin Invest 1973; 52: 2418–27

    Article  PubMed  CAS  Google Scholar 

  118. Pauwels A, Eliaszewicz M, Larrey D, et al. Pentamidine-induced pancreatitis in a patient with AIDS. J Clin Gastroenterol 1990; 12: 457–9

    Article  PubMed  CAS  Google Scholar 

  119. Herer B, Chient T, Labrune S, et al. Pentamidine associated with pentamidine by aerosol. BMJ 1989; 298: 605

    Article  PubMed  CAS  Google Scholar 

  120. Kumar S, Schnadig V, MacGregor M. Fatal acute pancreatitis associated with pentamidine therapy. Am J Gastroenterol 1989; 84: 451–3

    PubMed  CAS  Google Scholar 

  121. Salmeron S, Petitpretz P, Katlama C, et al. Pentamidine and pancreatitis. Ann Intern Med 1986; 105: 140–1

    PubMed  CAS  Google Scholar 

  122. Hart C. Aerosolized pentamidine and pancreatitis. Ann Intern Med 1989; 111: 691

    PubMed  CAS  Google Scholar 

  123. Schwartz M, Cappell M. Pentamidine-associated pancreatitis. Dig Dis Sci 1989; 34: 1617–20

    Article  PubMed  CAS  Google Scholar 

  124. Zuger A, Wolf B, El-Sadr W, et al. Pentamidine-associated fatal acute pancreatitis. JAMA 1986; 256: 2383–5

    Article  PubMed  CAS  Google Scholar 

  125. Foisy M, Slayter K, Hewitt R, et al. Pancreatitis during intravenous pentamidine therapy in an AIDS patient with prior exposure to didanosine. Ann Pharmacother 1994; 28: 1025–8

    PubMed  CAS  Google Scholar 

  126. Klatt E. Pathology of Pentamidine-induced pancreatitis. Arch Pathol Lab Med 1992; 116: 162–4

    PubMed  CAS  Google Scholar 

  127. Sauleda J, Gea J, Aguar M, et al. Probable pentamidine-induced pancreatitis. Ann Pharmacother 1994; 28: 52–3

    PubMed  CAS  Google Scholar 

  128. Pais J, Cazorla C, Novo E, et al. Massive haemorrhage from rupture of a pancreatic pseudocyst after pentamidine associated pancreatitis. Eur J Med 1992; 1: 251–3

    PubMed  CAS  Google Scholar 

  129. Singh G, El-Gadi S, Sparks R. Pancreatitis associated with aerosolised pentamidine. Genitourin Med 1995; 71: 130–1

    PubMed  CAS  Google Scholar 

  130. Murphey S, Josephs A. Acute pancreatitis associated with pentamidine therapy. Arch Intern Med 1981; 141: 56–8

    Article  PubMed  CAS  Google Scholar 

  131. Buchard P, Sai P, Reach G. Diabetes mellitus following pentamidine-induced hypoglycemia in humans. Diabetes 1982; 31: 40–5

    Article  Google Scholar 

  132. Boillot D, Veld P, Sai P. Functional and morphological modifications induced in rat islets by pentamidine and other diamidines in vitro. Diabetologia 1985; 28: 359–64

    Article  PubMed  CAS  Google Scholar 

  133. Waalkes T, Denham C, De Vita V. Pentamidine: clinical pharmacologic correlations in man and mice. Clin Pharmacol Ther 1970; 11: 505–12

    PubMed  CAS  Google Scholar 

  134. Roush M, McNutt R, Gray T. The adverse effect dilemma: quest for accessible information. Ann Intern Med 1993; 114: 298–9

    Google Scholar 

  135. Tilkemeier P, Thompson P. Acute pancreatitis possibly related to enalapril. N Engl J Med 1988; 318: 1275–6

    Article  PubMed  CAS  Google Scholar 

  136. Pedro-Botet J, Miralles R, Coll J, et al. Captopril versus enalapril: cough versus pancreatitis. DICP Ann Pharmacother 1990; 24: 438–9

    CAS  Google Scholar 

  137. Dabaghi S. ACE inhibitors and pancreatitis. Ann Intern Med 1991; 115: 330–1

    PubMed  CAS  Google Scholar 

  138. Maliekal J, Drake C. Acute pancreatitis associated with the use of lisinopril. Ann Pharmacother 1993; 27: 1465–6

    PubMed  CAS  Google Scholar 

  139. Standridge J. Fulminant pancreatitis associated with lisinopril therapy. South Med J 1994; 87: 179–81

    Article  PubMed  CAS  Google Scholar 

  140. Australian Adverse Drug Reaction Advisory Committee. Pancreatitis and ACE inhibitors [abstract]. Australian Adverse Drug Reactions Bulletin Aug 1989

    Google Scholar 

  141. Pratt C, Simone J, Zee P, et al. Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia. J Pediatr 1970; 77: 474–83

    Article  PubMed  CAS  Google Scholar 

  142. Tan C, Chang S, Wee K. Acute hemorrhagic pancreatitis following L-asparaginase therapy in acute lymphoblastic leukemia — a case report. Singapore Med J 1974; 15: 278–82

    PubMed  CAS  Google Scholar 

  143. Shaw M, Barnes C, Madden F, et al. L-asparaginase and pancreatitis. Lancet 1970; II: 721

    Article  Google Scholar 

  144. McLean R, Martin S, Lam-Po-Tang P. Fatal case of L-asparaginase induced pancreatitis. Lancet 1982; II: 1401–2

    Article  Google Scholar 

  145. Jain R, Ramanan S. Iatrogenic pancreatitis. A fatal complication in the induction therapy for acute lymphocytic leukemia. Arch Intern Med 1978; 138: 1726

    Article  PubMed  CAS  Google Scholar 

  146. Greenstein R, Nogeire C, Ohnuma T, et al. Management of aspariginase induced hemorrhagic pancreatitis complicated by pseudocyst. Cancer 1979; 43: 718–22

    Article  PubMed  CAS  Google Scholar 

  147. Halskell C, Canellos G, Leventhal B, et al. L-asparaginase — therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med 1969; 281: 1028–34

    Article  Google Scholar 

  148. Oettgen H, Stephenson P, Schwartz M, et al. Toxicity of E. coli L-asparaginase in man. Cancer 1970; 25: 253–78

    Article  PubMed  CAS  Google Scholar 

  149. Zubrod C. The clinical toxicities of L-asparaginase. Pediatrics 1970; 45: 555–8

    PubMed  CAS  Google Scholar 

  150. Whitecar J, Bodey G, Harris J, et al. Current concepts: L-asparaginase. N Engl J Med 1970; 282: 732–4

    Article  PubMed  Google Scholar 

  151. Loeb E, Hill J, Hill N, et al. Treatment of acute leukemia with L-asparaginase: recent results. Cancer Res 1970; 33: 204–18

    CAS  Google Scholar 

  152. Land V, Sutow W, Fernbach D, et al. Toxicity of L-asparaginase in children with advanced leukemia. Cancer 1972; 30: 339–47

    Article  PubMed  CAS  Google Scholar 

  153. Jaffe N, Traggis D, Das L, et al. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia. Pediatrics 1972; 49: 590–5

    PubMed  CAS  Google Scholar 

  154. Weetman R, Baehner R. Latent onset of clinical pancreatitis in children receiving L-asparaginase therapy. Cancer 1974; 34: 780–5

    Article  PubMed  CAS  Google Scholar 

  155. Samuels B, Culbert S, Okamura J, et al. Early detection of chemotherapy-related pancreatic enlargement in children using abdominal sonography: a preliminary report. Cancer 1976; 38: 1515–23

    Article  PubMed  CAS  Google Scholar 

  156. Nguyen D, Wilson D, Engelman E, et al. Serial sonograms to detect pancreatitis in children receiving L-asparaginase. South Med J 1987; 80: 1133–6

    Article  PubMed  CAS  Google Scholar 

  157. Schein P, Rakieten N, Gordon M, et al. The toxicity of Escher-ichia coli L-asparaginase. Cancer Res 1969; 29: 426–34

    PubMed  CAS  Google Scholar 

  158. Socinski M, Garwick M. Acute pancreatitis associated with chemotherapy for germ cell tumors in two patients. Ann Intern Med 1988; 108: 567–8

    PubMed  CAS  Google Scholar 

  159. Puckett J, Butler W, McFarland J. Pancreatitis and cancer chemotherapy. Ann Intern Med 1982; 97: 453

    PubMed  CAS  Google Scholar 

  160. Newman C, Ellis D. Pancreatitis during combination chemotherapy. Clin Oncol 1979; 5: 83–4

    PubMed  CAS  Google Scholar 

  161. Nevalainen T. Cytotoxicity of vinblastine and vincristine to pancreatic acinar cells. Virchows Arch B Cell Pathol 1975; 18: 119–27

    PubMed  CAS  Google Scholar 

  162. Lerche A, Vyberg M, Kirkegaard E. Acute cholangitis and pancreatitis associated with sulindac. Histopathology 1987; 11: 647–53

    Article  PubMed  CAS  Google Scholar 

  163. Zygmunt D, Williams H, Bienz S. Acute pancreatitis associated with long-term sulindac therapy. West J Med 1986; 144: 461–2

    PubMed  CAS  Google Scholar 

  164. Sugerman H. Sulindac-induced acute pancreatitis mimicking gallstone pancreatitis. Am Surg 1989; 55: 536–8

    PubMed  CAS  Google Scholar 

  165. Goldstein J, Laskin D, Ginsberg G. Sulindac associated with pancreatitis. Ann Intern Med 1980; 93: 115

    Google Scholar 

  166. Lilly E. Pancreatitis after administration of sulindac. JAMA 1981; 246: 2680

    Article  PubMed  CAS  Google Scholar 

  167. Memon A. Pancreatitis and sulindac. Ann Intern Med 1982; 96: 139

    Google Scholar 

  168. Siefkin A. Sulindac and pancreatitis. Ann Intern Med 1980; 93: 932–3

    PubMed  CAS  Google Scholar 

  169. Klein S, Khan M. Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac therapy. J Rheumatol 1983; 10: 512–3

    PubMed  CAS  Google Scholar 

  170. Svane S. Acute pancreatitis after treatment with sulindac [Norwegian]. Tidsskr Nor Laegeforen 1992; 112: 1453

    PubMed  CAS  Google Scholar 

  171. Guerra M. Toxicity of indomethacin: report of a case of acute pancreatitis. JAMA 1967; 200: 552–3

    Article  PubMed  CAS  Google Scholar 

  172. Cobb T, Piero J. Acute pancreatitis associated with Ketoprofen. South Med J 1992; 85: 430–1

    Article  PubMed  CAS  Google Scholar 

  173. Khan I, Edward N. Pancreatitis associated with diclofenac. Postgrad Med J 1993; 69: 486–7

    Article  PubMed  CAS  Google Scholar 

  174. Du Ville L, Debeuckelaere S, Reynaert H, et al. Pancreatitis associated with Naproxen. Gastroenterology 1993; 88: 464

    Google Scholar 

  175. Sussmann S. Severe salicylism and acute pancreatitis Calif Med 1963; 99: 29–32

    Google Scholar 

  176. Cabooter M, Elewaut A, Barbier F. Salicylate-induced pancreatitis. Gastroenterology 1981; 80: 214–5

    PubMed  CAS  Google Scholar 

  177. Haye O. Piroxicam and pancreatitis. Ann Intern Med 1986; 104: 895

    PubMed  CAS  Google Scholar 

  178. Van Waalraven A, Edels M, Fong S. Pancreatitis caused by mefenaminic acid. Can Med Assoc J 1982; 126: 894

    Google Scholar 

  179. Bosch J, Valdes M, Oristrell J, et al. Oxyphenbutazone-induced sialadenitis, intrahepatic cholestasis and pancreatitis. Acta Gastroenterol Belg 1985; 48: 529–30

    PubMed  CAS  Google Scholar 

  180. Ruppert G, Barth W. Ibuprofen hypersensitivity in systemic lupus erythematosus. South Med J 1981; 74: 241–2

    Article  PubMed  CAS  Google Scholar 

  181. Caldarola V, Hassett J, Hall A, et al. Hemorrhagic pancreatitis associated with acetaminophen overdose. Am J Gastroenterol 1986; 81: 579–81

    PubMed  CAS  Google Scholar 

  182. Coward R. Paracetamol induced acute pancreatitis. BMJ 1977; 1: 1086

    Article  PubMed  CAS  Google Scholar 

  183. Gilmore I, Tourvas E. Paracetamol-induced acute pancreatitis. BMJ 1977; 1: 753

    Article  PubMed  CAS  Google Scholar 

  184. Mofenson H, Caraccio T, Nawaz H, et al. Acetaminophen induced pancreatitis. J Toxicol Clin Toxicol 1991; 29: 223–30

    Article  PubMed  CAS  Google Scholar 

  185. Olazabal A, Nascimento L. Effect of indomethacin, aspirin and fat-free diet on experimental pancreatitis in the rat. J Lab Clin Med 1980; 96: 570–6

    PubMed  CAS  Google Scholar 

  186. Lankisch P, Koop H, Winkle K, et al. Indomethacin treatment of acute experimental pancreatitis in the rat. Scand J Gastroenterol 1978; 13: 629–33

    Article  PubMed  CAS  Google Scholar 

  187. Jubert P. Clozapine related pancreatitis. Ann Intern Med 1994; 121: 722–3

    PubMed  CAS  Google Scholar 

  188. Martin A. Acute pancreatitis associated with clozapine use. Am J Psychiatry 1992; 149: 714

    PubMed  CAS  Google Scholar 

  189. Frankenburg F, Kando J. Eosinophilia, clozapine and pancreatitis. Lancet 1992; 340: 251

    Article  PubMed  CAS  Google Scholar 

  190. Aziz S, Bergdahl L, Baldwin J, et al. Pancreatitis after cardiac and cardiopulmonary transplantation. Surgery 1985; 97: 653–61

    PubMed  CAS  Google Scholar 

  191. Penn I, Durst A, Machado M, et al. Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg 1975; 105: 167–72

    Article  Google Scholar 

  192. Renning J, Warden G, Stevens L, et al. Pancreatitis after renal transplantation. Am J Surg 1972; 123: 293–6

    Article  PubMed  CAS  Google Scholar 

  193. Johnson W, Nabseth D. Pancreatitis in renal transplantation. Ann Surg 1970; 171: 309–14

    Article  PubMed  CAS  Google Scholar 

  194. Corrodi P, Knoblauch M, Binswanger U, et al. Pancreatitis after renal transplantation. Gut 1975; 16: 285–9

    Article  PubMed  CAS  Google Scholar 

  195. Yoshimura N, Nakai I, Ohmori Y, et al. Effect of cyclosporine on endocrine and exocrine pancreas in kidney transplant recipients. Am J Kidney Dis 1988; 12: 11–7

    PubMed  CAS  Google Scholar 

  196. Frick T, Fryd D, Goodale R, et al. Lack of association between azathioprine and acute pancreatitis in renal transplantation patients. Lancet 1991; 337: 251–2

    Article  PubMed  CAS  Google Scholar 

  197. Sturdevant R, Singleton J, Deren J, et al. Azathioprine-related pancreatitis in patients with Crohn’s disease. Gastroenterology 1979; 77: 883–6

    PubMed  CAS  Google Scholar 

  198. Huizenga K, Shorter R, Phillips S. Pancreatitis: a specific complication of azathioprine treatment of Crohn’s disease [abstract]. Gastroenterology 1976; 70: 895

    Google Scholar 

  199. Nogueira J, Freedman M. Acute pancreatitis as a complication of imuran therapy in regional enteritis. Gastroenterology 1972; 62: 1040–1

    PubMed  CAS  Google Scholar 

  200. Major G, Moore P. Profound circulatory collapse due to azathioprine. J Royal Soc Med 1985; 78: 1052–3

    CAS  Google Scholar 

  201. Kawanishi H, Rudolph E, Bull F. Azathioprine-induced acute pancreatitis. N Engl J Med 1973; 289: 357

    Article  PubMed  CAS  Google Scholar 

  202. Isenberg J. Pancreatitis, amylase clearance, and azathioprine. J Pediatrics 1978; 93: 1043–4

    Article  CAS  Google Scholar 

  203. Guillaume P, Grandjean E, Male P. Azathioprine-associated acute pancreatitis in the course of chronic active hepatitis. Dig Dis Sci 1984; 29: 78–80

    Article  PubMed  CAS  Google Scholar 

  204. Paloyan D, Levin B, Simonowitz D. Azathioprine-associated acute pancreatitis. Am J Dig Dis 1977; 22: 839–40

    Article  PubMed  CAS  Google Scholar 

  205. Hamed I, Lindeman R, Czerwinski A. Acute pancreatitis following corticosteroid and azathioprine therapy. Am J Med Sci 1978; 276: 211–9

    Article  PubMed  CAS  Google Scholar 

  206. Broe P, Cameron J. Azathioprine and acute pancreatitis: Studies with an isolated perfused canine pancreas. J Surg Res 1983; 34: 159–63

    Article  PubMed  CAS  Google Scholar 

  207. Dreiling D, Nacchiero M. The effect of imuran on pancreatic secretion. Am J Gastroenterol 1978; 69: 491–3

    PubMed  CAS  Google Scholar 

  208. Kerstein M, Grabman J. Azathioprine as a treatment modality in acute hemorrhagic pancreatitis. Surg Forum 1978; 29: 453

    PubMed  CAS  Google Scholar 

  209. Stenvinkel P, Alvestrand A. Loop diuretic-induced pancreatitis with rechallenge in a patient with malignant hypertension and renal insufficiency. Acta Med Scand 1988; 224: 89–91

    Article  PubMed  CAS  Google Scholar 

  210. Buchanan N, Cane R. Frusemide-induced pancreatitis. BMJ 1977; 3: 1417

    Article  Google Scholar 

  211. Call T, Malarkey W, Thomas F. Acute pancreatitis secondary to furosemide with associated hyperlipidemia. Am J Dig Dis 1977; 22: 835–8

    Article  PubMed  CAS  Google Scholar 

  212. Jones P, Oelbaum M. Frusemide-induced pancreatitis. BMJ 1975; i: 133–4

    Article  Google Scholar 

  213. Strunge P. Frusemide-induced pancreatitis [letter]? BMJ 1975; 3: 434

    Article  PubMed  CAS  Google Scholar 

  214. Wilson A, Mehra S, Gomersall C, et al. Acute pancreatitis associated with frusemide therapy. Lancet 1967; I: 105

    Article  Google Scholar 

  215. Thomas F, Sinar D, Caldwell J, et al. Stimulation of pancreatic secretion of water and electrolytes by furosemide. Gastroenterology 1977; 73: 221–5

    PubMed  CAS  Google Scholar 

  216. Schultz J, Adamson J, Workman W, et al. Fatal liver disease after intravenous administration of tetracycline in high dosage. N Engl J Med 1963; 269: 999–1004

    Article  PubMed  CAS  Google Scholar 

  217. Kunelis C, Peters J, Edmondson H. Fatty liver of pregnancy and its relationship to tetracycline therapy. Am J Med 1965; 38: 359–77

    Article  PubMed  CAS  Google Scholar 

  218. Whalley P, Adams R, Combes B. Tetracycline toxicity in pregnancy. JAMA 1964; 189: 357–62

    Article  PubMed  CAS  Google Scholar 

  219. Peters R, Edmondson H, Mikkelsen W, et al. Tetracycline-induced fatty liver in non-pregnant women. Am J Surg 1967; 113: 622–32

    Article  PubMed  CAS  Google Scholar 

  220. Damjanov I, Arnold R, Faour M. Tetracycline toxicity in a non-pregnant woman. JAMA 1968; 204: 934

    Article  PubMed  CAS  Google Scholar 

  221. Jordan S, Ament M. Pancreatitis in children and adolescents. J Pediatr 1977; 91: 211–6

    Article  PubMed  CAS  Google Scholar 

  222. Nicolau D, Mengedoht D, Kline J. Tetracycline-induced pancreatitis. Am J Gastroenterol 1991; 86: 1669–71

    PubMed  CAS  Google Scholar 

  223. Torosis J, Vender R. Tetracycline-induced pancreatitis. J Clin Gastroenterol 1987; 9: 580–1

    Article  PubMed  CAS  Google Scholar 

  224. Elmore M, Rogge J. Tetracycline-induced pancreatitis Gastroenterology 1981; 81: 1134–6

    PubMed  CAS  Google Scholar 

  225. Celifarco A, Warschauer C, Burakoff R. Metronidazole-induced pancreatitis. Am J Gastroenterol 1989; 84: 958–60

    PubMed  CAS  Google Scholar 

  226. Plotnick B, Cohen I, Tsang T, et al. Metronidazole-induced pancreatitis. Ann Intern Med 1985; 103: 891–2

    PubMed  CAS  Google Scholar 

  227. Sanford K, Mayle J, Dean H, et al. Metronidazole-associated pancreatitis. Ann Intern Med 1988; 109: 756–7

    PubMed  CAS  Google Scholar 

  228. Corey W, Doebbeling B, DeJong K, et al. Metronidazole-induced acute pancreatitis. Rev Infect Dis 1991; 13: 1213–5

    Article  PubMed  CAS  Google Scholar 

  229. Friedman G, Selby J. How often does metronidazole induce pancreatitis? Gastroenterology 1990; 98: 1702–3

    PubMed  CAS  Google Scholar 

  230. Sanford K, Mayle J, Dean H, et al. Excessive drug challenge. Ann Intern Med 1989; 110: 410

    Google Scholar 

  231. Scharer L, Smith J. Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid. Ann Intern Med 1969; 71: 1113–20

    PubMed  CAS  Google Scholar 

  232. Goldman A, Braman S. Isoniazid: a review with emphasis on adverse effects. Chest 1972; 62: 71–7

    Article  PubMed  CAS  Google Scholar 

  233. Davidson P, Le H. Drug treatment of tuberculosis. Drugs 1992; 43: 651–73

    Article  PubMed  CAS  Google Scholar 

  234. Chan K, Chan H, Lui S, et al. Recurrent acute pancreatitis induced by isoniazid. Tuber Lung Dis 1994; 75: 383–5

    Article  PubMed  CAS  Google Scholar 

  235. Rabassa A, Trey G, Shukla U, et al. Isoniazid-induced pancreatitis. Ann Intern Med 1994; 121: 433–4

    PubMed  CAS  Google Scholar 

  236. Dickson I. Acute pancreatitis following administration of Iso nicotinic acid hydrazide. Br J Tuberculosis 1956; 50: 277

    Article  CAS  Google Scholar 

  237. Perry W, Jenkins M, Stamp T. Lysosomal enzymes and pancreatitis during rifampicin therapy. Lancet 1979; I: 492

    Article  Google Scholar 

  238. Riska N, Mattson K. Adverse reactions during rifampicin treatment. Scand J Respir Dis 1972; 53: 87–96

    PubMed  CAS  Google Scholar 

  239. Mattson K. Side effects of rifampicin. Scand J Respir Dis 1973; 82 Suppl.: 1–52

    CAS  Google Scholar 

  240. Poole G, Stradling P, Worlledge S. Potentially serious side effects of high-dose twice-weekly rifampicin. BMJ 1971; 3: 343–7

    Article  PubMed  CAS  Google Scholar 

  241. Brockner J, Boisen E. Fatal multisystem toxicity after co-trimoxazole. Lancet 1978; I: 831

    Article  Google Scholar 

  242. Bartels R, van der Spek J, Oosten H. Acute pancreatitis due to sulfamethoxazole-trirnethoprim. South Med J 1992; 85: 1006–7

    Article  PubMed  CAS  Google Scholar 

  243. Barret P, Thier S. Meningitis and acute pancreatitis associated with sulfamethoxazole. N Engl J Med 1963; 268: 36–7

    Article  Google Scholar 

  244. Antonow D. Acute pancreatitis associated with trimethoprim-sulfamethoxazole. Ann Intern Med 1986; 104: 363–5

    PubMed  CAS  Google Scholar 

  245. Christophe J. Pancreatitis induced by nitrofurantoin. Gut 1993; 35: 712–3

    Article  Google Scholar 

  246. Nelis G. Nitrofurantoin-induced pancreatitis: report of a case. Gastroenterology 1983; 84: 1032–4

    PubMed  CAS  Google Scholar 

  247. Davis T, Keeffe EB. Acute pancreatitis and acute hepatitis A. Am J Gastroenterol 1992; 87: 1648–50

    PubMed  CAS  Google Scholar 

  248. Meylan P, Calandra T, Casey P, et al. Clinical experience with timetin in severe hospital infections. J Antimicrob Chemother 1986; 17 Suppl. C: 127–39

    PubMed  Google Scholar 

  249. Hanline M. Acute pancreatitis caused by ampicillin. South Med J 1987; 80: 1069

    Article  PubMed  Google Scholar 

  250. Hawksworth C. Acute pancreatitis associated with infusion of erythromycin lactobionate. BMJ 1989; 298: 190

    Article  PubMed  CAS  Google Scholar 

  251. Gumaste V. Erythromycin-induced pancreatitis. Am J Med 1989; 86: 725

    Article  PubMed  CAS  Google Scholar 

  252. Berger T, Cook W, O’Marcaigh A, et al. Acute pancreatitis in a 12 year old girl after an erythromycin overdose. Pediatrics 1992; 90: 624–6

    PubMed  CAS  Google Scholar 

  253. Steed D, Brown B, Reilly J, et al. General surgical complications in heart and heart-lung transplantation. Surgery 1985; 98: 739–44

    PubMed  CAS  Google Scholar 

  254. Calvo D, Patt Y, Wallace S, et al. Phase I-II trial of percutaneous intra-arterial cis-diamminedichloro platinum (II) for regionally confined malignancy. Cancer 1980; 45: 1278–83

    Article  PubMed  Google Scholar 

  255. Bunin N, Meyer W, Christensen M, et al. Pancreatitis following cisplatin: a case report. Cancer Treat Rep 1985; 69: 236–7

    PubMed  CAS  Google Scholar 

  256. Bank L, Wright J. 6-mercaptopurine-related pancreatitis in 2 patients with inflammatory bowel disease. Dig Dis Sci 1984; 29: 357–9

    Article  PubMed  CAS  Google Scholar 

  257. Haber C, Meltzer S, Present D, et al. Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease. Gastroenterology 1986; 91: 982–6

    PubMed  CAS  Google Scholar 

  258. Present D, Korelitz B, Wisch N, et al. Treatment of Crohn’s disease with 6-mercaptopurine. N Engl J Med 1980; 302: 981–7

    Article  PubMed  CAS  Google Scholar 

  259. Heuser E, Liebermann E, Donnell G, et al. Subcutaneous fat necrosis with acute hemorrhagic pancreatitis. Calif Med 1967; 106: 58–63

    PubMed  CAS  Google Scholar 

  260. Cappell M, Das K. Rapid development of pancreatitis following reuse of 6-mercaptopurine. J Clin Gastroenterol 1989; 11: 679–81

    Article  PubMed  CAS  Google Scholar 

  261. Woolley P, III. Hepatic and pancreatic damage produced by cytotoxic drugs. Cancer Treat Rev 1983; 10: 117–37

    Article  PubMed  Google Scholar 

  262. Altman A, Dinndorf P, Quinn J. Acute pancreatitis in association with cytosine arabinoside therapy. Cancer 1982; 49: 1384–6

    Article  PubMed  CAS  Google Scholar 

  263. Siemers R, Friedenberg W, Norflee R. High-dose cytosine arabinoside-associated pancreatitis. Cancer 1985; 56: 1940–2

    Article  PubMed  CAS  Google Scholar 

  264. Izraeli S, Adamson P, Blaney S, et al. Acute pancreatitis after ifosfamide therapy. Cancer 1994; 74: 1627–8

    Article  PubMed  CAS  Google Scholar 

  265. Lee S, Nichols J, Park H. Biliary sludge as a cause of acute pancreatitis. N Engl J Med 1992; 326: 589–93

    Article  PubMed  CAS  Google Scholar 

  266. Békássy A, Wiebe T, Hochbergs P. Erwinase-induced pancreatitis. Lancet 1992; 340: 1552–3

    Article  PubMed  Google Scholar 

  267. Kaplan M, Dreiling D. Steroids revised. Part II. Was cortisone responsible for the pancreatitis? Am J Gastroenterol 1977; 67: 141–7

    PubMed  CAS  Google Scholar 

  268. Steinberg W, Lewis J. Steroid-induced pancreatitis: does it really exist? Gastroenterology 1981; 81: 799–808

    PubMed  CAS  Google Scholar 

  269. Frick T, Speiser D, Bimmler D, et al. Drug-induced pancreatitis: further criticism. Dig Dis 1993; 11: 113–32

    Article  PubMed  CAS  Google Scholar 

  270. Wilde H. Pancreatitis and phenformin. Ann Intern Med 1972; 77: 324

    PubMed  CAS  Google Scholar 

  271. Coodley E, Derasse J, Carver J. Phenformin and pancreatitis. Ann Intern Med 1973; 78: 307

    PubMed  CAS  Google Scholar 

  272. Chase H, Morgan G. Phenformin-associated pancreatitis. Ann Intern Med 1977; 87: 314–5

    PubMed  Google Scholar 

  273. Graeber G, Marmor B, Hendel RC, et al. Pancreatitis and severe metabolic abnormalities due to phenformin therapy. Arch Surg 1976; 111: 1014–6

    Article  PubMed  CAS  Google Scholar 

  274. Levitan A. Phenformin and pancreatitis. Ann Intern Med 1973; 78: 306–7

    PubMed  CAS  Google Scholar 

  275. Ryan L, Hankwitz P, Banasiak M. Phenformin and pancreatitis. Ann Intern Med 1977; 87: 796

    PubMed  CAS  Google Scholar 

  276. Wu S, Wolf J. Phenformin and pancreatitis. Ann Intern Med 1978; 88: 128

    PubMed  CAS  Google Scholar 

  277. Sastri SV, Diaz-Arias AA, Marshall JB. Can pancreatitis be associated with amiodarone hepatotoxicity? J Clin Gastroenterol 1990; 12: 70–7

    Article  PubMed  CAS  Google Scholar 

  278. Sebastian Domingo J, Simon Marco M, Uribarrena Echebarria R. Hepatic and pancreatic injury associated with amineptine therapy. J Clin Gastroenterol 1994; 18: 168–9

    Article  PubMed  CAS  Google Scholar 

  279. Branch A. Pancreatic necrosis in ethyl alcohol, methyl alcohol and arsenic poisoning. Can Med Assoc J 1944; 51: 428–30

    PubMed  CAS  Google Scholar 

  280. Durrington PN, Cairns SA. Acute pancreatitis: a complication of beta-blockade. BMJ 1982; 284: 1016

    Article  PubMed  CAS  Google Scholar 

  281. Soman M, Swenson C. A possible cause of carbamazepine-induced pancreatitis. Drug Intell Clin Pharm 1985; 19: 925–6

    PubMed  CAS  Google Scholar 

  282. Tsao C, Wright F. Acute chemical pancreatitis associated with carbamazepine intoxication. Epilepsia 1993; 34: 174–6

    Article  PubMed  CAS  Google Scholar 

  283. Speckmann K. Über Pankreasschädigungen durch Tetrachlorkohlenstoff. Arztl Wochenschr 1953; 8: 1051–2

    CAS  Google Scholar 

  284. Moon HD. The pathology of fatal carbon-tetrachloride poisoning with special reference to the histogenesis of the hepatic and renal lesions. Am J Pathol 1950; 26: 1041–57

    PubMed  CAS  Google Scholar 

  285. Keane FBV, Fennell JS, Tomkin GH. Acute pancreatitis, acute gastric dilatation and duodenal ileus following refeeding in anorexia nervosa. Ir J Med Sci 1978; 147: 191–2

    Article  PubMed  CAS  Google Scholar 

  286. Casdorph HR. The efficacy and safety of cholestyramine therapy in hyperlipidemic patients. Ann Intern Med 1971; 74: 818

    Google Scholar 

  287. Committee of Principal Investigators. A co-operative trial in the primary prevention of ischemic heart disease using clofibrate. Br Heart J 1978; 40: 1069–118

    Article  Google Scholar 

  288. Roberge R, Martin T, Hodgman M, et al. Acute chemical pancreatitis associated with a tricyclic antidepressant (clomipramine) overdose. Clin Toxicol 1994; 32: 425–9

    Article  CAS  Google Scholar 

  289. Freemann JS, Panebianco PS. Colchicine overdosage: report of a case. J Am Osteopath Assoc 1982; 82: 252–4

    Google Scholar 

  290. Naidus RM, Rodvien R, Mielke H. Colchicine toxicity. Arch Intern Med 1977; 137: 394–6

    Article  PubMed  CAS  Google Scholar 

  291. Chevalier X, Awada H, Baetz A, et al. Danazol induced pancreatitis and hepatitis. Clin Rheumatol 1990; 9: 239–41

    Article  PubMed  CAS  Google Scholar 

  292. McCormick PA, O’Donoghue D, Brennan N. Diphenoxylate and pancreatitis. Lancet 1985; I: 752

    Article  Google Scholar 

  293. Deviere J, Reuse C, Askenasi R. Ischemic pancreatitis and hepatitis secondary to ergotamine poisoning. J Clin Gastroenterol 1987; 9: 350–2

    Article  PubMed  CAS  Google Scholar 

  294. Thys F, Schapira M, Ghilain J, et al. Acute pancreatitis and fenfluramine. Gastroenterol Clin Biol 1994; 18: 385–6

    PubMed  CAS  Google Scholar 

  295. Tchantz P, Favre H. Pancréatite nécrosante par intoxication à l’acide formique et brûlure à l’acide fluorhydrique. Schweiz Rundsch Med Prax 1975; 64: 487–90

    Google Scholar 

  296. Eisemann AD, Becker NJ, Miner PB, et al. Pancreatitis and gold treatment of rheumatoid arthritis. Ann Intern Med 1989; 111: 860–1

    PubMed  CAS  Google Scholar 

  297. Schrogi JJ, Holt P, Hartley RC, et al. ‘Histamine-induced’ pancreatitis. Gastroenterology 1965; 49: 672–5

    Google Scholar 

  298. Calmus Y, Biour M, Bodin F, et al. Hépatites et pancréatite à l’indalpine. Gastroenterol Clin Biol 1985; 9: 266–8

    PubMed  CAS  Google Scholar 

  299. Noseworthy J, Colodny AH, Eraklis AJ. Pancreatitis and intravenous fat: an association in patients with inflammatory bowel disease. J Pediatr Surg 1983; 18: 269–72

    Article  PubMed  CAS  Google Scholar 

  300. Buckspan R, Woltering E, Waterhouse G. Pancreatitis induced by intravenous infusion of a fat emulsion in an alcoholic patient. South Med J 1984; 77: 251–2

    Article  PubMed  CAS  Google Scholar 

  301. Lashner BA, Kirsner JB, Hanauer SB. Acute pancreatitis associated with high-concentration lipid emulsion during total parenteral nutrition therapy for Crohn’s disease. Gastroenterology 1986; 90: 1039–41

    PubMed  CAS  Google Scholar 

  302. Flynn WJ, Freeman PG, Wickboldt LG. Pancreatitis associated with isotretinoin-induced hypertriglyceridemia. Ann Intern Med 1987; 107: 63

    PubMed  CAS  Google Scholar 

  303. Pluhar W. Ein Fall möglicher Lovastatin-induzierter Pankreatitis bei gleichzeitigem Gilbert-Syndrom. Wien Klin Wochenschr 1989; 101: 551–4

    PubMed  CAS  Google Scholar 

  304. Bourry J, Sainty JM, Roux JJ, et al. Pancréatites aiguès aucours d’intoxications au méprobamate. Nouv Presse Med 1976; 5: 1918

    PubMed  CAS  Google Scholar 

  305. Meyers DH. Pancreatitis, panniculitis and methandienone. Aust NZJ Med 1982; 12: 302–5

    CAS  Google Scholar 

  306. Sanford EW, Mitas JA, Swerdlin AHR. Pancreatitis due to methyldopa: case report. Mil Med 1980; 145: 399–400

    Google Scholar 

  307. Rominger JM, Gutierrez JG, Curtis D, et al. Methyldopa-induced pancreatitis. Am J Dig Dis 1978; 23: 756–8

    Article  PubMed  CAS  Google Scholar 

  308. Van der Heide H, Ten Haaft MA, Strieker BMC. Pancreatitis caused by methyldopa. BMJ 1981; 282: 1930–1

    Article  PubMed  Google Scholar 

  309. Stecyk O, Loludice TA, Demeter S, et al. Multiple organ failure resulting from intravenous abuse of methylphenidate hydrochloride. Ann Emerg Med 1985; 14: 597–9

    Article  PubMed  CAS  Google Scholar 

  310. Tan W, Chapnick E, Abter E, et al. Paromycin-associated pancreatitis in HIV-related cryptosporidosis. Ann Pharmacother 1995; 29: 22–4

    PubMed  CAS  Google Scholar 

  311. Bennett IL, Nation TC, Olley JF. Pancreatitis in methyl alcoholic poisoning. J Lab Clin Med 1952; 40: 405–9

    PubMed  CAS  Google Scholar 

  312. Bennett IL, Freeman HC, Mitchell GL, et al. Acute methyl alcohol poisoning: a review based on experiences in an outbreak of 323 cases. Medicine 1953; 32: 431–63

    Article  PubMed  Google Scholar 

  313. Alberti Flor J. Pancreatitis associated with ondansetron. J Natl Cancer Inst 1995; 87: 689–90

    Article  PubMed  CAS  Google Scholar 

  314. Braganza JM, Jolley JE, Lee WR. Occupational chemicals and pancreatitis: a link? Int J Pancreatol 1986; 1: 9–19

    PubMed  CAS  Google Scholar 

  315. Gradon J, Shulman R, Chapnick E, et al. Octreotide induced pancreatitis in a patient with acquired immunodeficiency syndrome. South Med J 1991; 84: 1410–1

    Article  PubMed  CAS  Google Scholar 

  316. Friedenrich A, Sosset C, Bernard J, et al. Acute pancreatitis after short-term octreotide. Lancet 1991; 338: 52

    Article  Google Scholar 

  317. Lambrianides AL, Rosin RD. Acute pancreatitis complicating excessive intake of phenolphthalein. Postgrad Med J 1984; 60: 491–2

    Article  PubMed  CAS  Google Scholar 

  318. Middleton SJ, Jacyna M, McClaren D, et al. Thomas HC. Hemorrhagic pancreatitis — a cause of death in severe potassium permanganate poisoning. Postgrad Med J 1990; 66: 657–8

    Article  PubMed  CAS  Google Scholar 

  319. Falco JM, Thomas FB. Acute pancreatitis due to procainamide-induced lupus erythematosus. Ann Intern Med 1975; 83: 832–3

    Google Scholar 

  320. Jeffries JJ, Masson J. Pancreatitis following overdose with amoxapine and procyclidine. Can J Psychiatry 1985; 30: 546–7

    PubMed  CAS  Google Scholar 

  321. Larsen RR, Sawyer RB, Sawyer KC, et al. Hemorrhagic pancreatitis complicating anticoagulant therapy. NY State J Med 1962; XX: 2397–9

    Google Scholar 

  322. Satake K, Nakashima Y. Drug-induced pancreatitis Philadelphia: Lea & Febiger, 1987: 322–9

    Google Scholar 

  323. Nakashima Y, Howard J. Drug-induced acute pancreatitis. Surg Gynecol Obstet 1977; 145: 105–9

    PubMed  CAS  Google Scholar 

  324. Mallory A, Kern F. Drug-induced pancreatitis: a critical review. Gastroenterology 1980; 78: 813–20

    PubMed  CAS  Google Scholar 

  325. Mallory A, Kern F. Drug-induced pancreatitis. Baillieres Clin Gastroenterol 1988; 2: 293–307

    Article  PubMed  CAS  Google Scholar 

  326. Steinberg W. Acute drug and toxin induced pancreatitis. Hosp Pract Off Ed 1985; 20: 95–102

    PubMed  CAS  Google Scholar 

  327. Banerjee A, Patel K, Grainger S. Drug-induced acute pancreatitis: a critical review. Med Toxicol Adverse Drug Exper 1989; 4: 186–98

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 2QQ, England

    Teun Wilmink &  Thomas W. Frick

Authors
  1. Teun Wilmink
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas W. Frick
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilmink, T., Frick, T.W. Drug-Induced Pancreatitis. Drug-Safety 14, 406–423 (1996). https://doi.org/10.2165/00002018-199614060-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199614060-00006

Keywords

Search

Navigation